tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CDTX Stock Latest News

Cidara Therapeutics price target raised to $110 from $74 at H.C. Wainwright
The FlyCidara Therapeutics price target raised to $110 from $74 at H.C. Wainwright
3d ago
CDTX
Cidara Therapeutics doses first patient in CD388 trial
PremiumThe Fly
Cidara Therapeutics doses first patient in CD388 trial
4d ago
CDTX
Cidara Therapeutics Expands Phase 3 Trial for CD388
PremiumCompany Announcements
Cidara Therapeutics Expands Phase 3 Trial for CD388
4d ago
8K
CDTX
Cidara Therapeutics price target raised to $153 from $66 at Citizens JMP
PremiumThe Fly
Cidara Therapeutics price target raised to $153 from $66 at Citizens JMP
5d ago
CDTX
Cidara Therapeutics price target raised to $100 from $74 at Needham
PremiumThe Fly
Cidara Therapeutics price target raised to $100 from $74 at Needham
5d ago
CDTX
Cidara Therapeutics’ Accelerated Path to BLA Approval and Expanded Market Potential Boosts Buy Rating
PremiumRatingsCidara Therapeutics’ Accelerated Path to BLA Approval and Expanded Market Potential Boosts Buy Rating
5d ago
CDTX
Accelerated Phase 3 Study and Expanded Market Potential Make Cidara Therapeutics a Strong Buy
Premium
Ratings
Accelerated Phase 3 Study and Expanded Market Potential Make Cidara Therapeutics a Strong Buy
5d ago
CDTX
Cidara Therapeutics price target raised to $167 from $70 at Guggenheim
Premium
The Fly
Cidara Therapeutics price target raised to $167 from $70 at Guggenheim
5d ago
CDTX
Cidara announced several positive CD388 updates, says H.C. Wainwright
PremiumThe Fly
Cidara announced several positive CD388 updates, says H.C. Wainwright
5d ago
CDTX
Cidara Therapeutics price target raised to $137 from $115 at RBC Capital
PremiumThe Fly
Cidara Therapeutics price target raised to $137 from $115 at RBC Capital
5d ago
CDTX
Cidara Therapeutics announces expanded, accelerated Phase 3 plan for CD388
PremiumThe Fly
Cidara Therapeutics announces expanded, accelerated Phase 3 plan for CD388
5d ago
CDTX
Cidara Therapeutics price target raised to $123 from $45 at WBB Securities
PremiumThe Fly
Cidara Therapeutics price target raised to $123 from $45 at WBB Securities
7d ago
CDTX
Cidara Therapeutics presents data on CD388 from Phase 2b NAVIGATE trial
PremiumThe FlyCidara Therapeutics presents data on CD388 from Phase 2b NAVIGATE trial
12d ago
CDTX
Cidara Therapeutics: Promising Trials Amidst Financial Challenges
Premium
Company Announcements
Cidara Therapeutics: Promising Trials Amidst Financial Challenges
2M ago
CDTX
Cidara Therapeutics price target raised to $74 from $54 at Needham
Premium
The Fly
Cidara Therapeutics price target raised to $74 from $54 at Needham
2M ago
CDTX
Cidara Therapeutics price target raised to $70 from $69 at Guggenheim
PremiumThe Fly
Cidara Therapeutics price target raised to $70 from $69 at Guggenheim
2M ago
CDTX
Cidara Therapeutics price target raised to $74 from $53 at H.C. Wainwright
PremiumThe Fly
Cidara Therapeutics price target raised to $74 from $53 at H.C. Wainwright
2M ago
CDTX
Cidara Therapeutics price target raised to $66 from $59 at Citizens JMP
PremiumThe Fly
Cidara Therapeutics price target raised to $66 from $59 at Citizens JMP
2M ago
CDTX
Cidara Therapeutics Reports Positive Trial Results and Financial Growth
PremiumCompany Announcements
Cidara Therapeutics Reports Positive Trial Results and Financial Growth
2M ago
CDTX
Cidara Therapeutics reports Q2 EPS ($1.65), consensus ($1.82)
PremiumThe FlyCidara Therapeutics reports Q2 EPS ($1.65), consensus ($1.82)
2M ago
CDTX
Cidara Therapeutics price target raised to $115 from $75 at RBC Capital
Premium
The Fly
Cidara Therapeutics price target raised to $115 from $75 at RBC Capital
2M ago
CDTX
Cidara Therapeutics price target raised to $69 from $68 at Guggenheim
Premium
The Fly
Cidara Therapeutics price target raised to $69 from $68 at Guggenheim
3M ago
CDTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >